SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    J. Spoendlin, J.J. Voegel, S.S. Jick, C.R. Meier, Antihypertensive drugs and the risk of incident rosacea, British Journal of Dermatology, 2014, 171, 1
  2. 2
    Luc Poirier, Sheldon W. Tobe, Contemporary Use of β-Blockers: Clinical Relevance of Subclassification, Canadian Journal of Cardiology, 2014, 30, 5, S9

    CrossRef

  3. 3
    James W. Schurr, Brenda Gitman, Yuly Belchikov, Controversial Therapeutics: The β-Adrenergic Antagonist and Cocaine-Associated Cardiovascular Complications Dilemma, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2014, 34, 9
  4. 4
    Neng Dai, DaChun Xu, Ji Zhang, YiDong Wei, WeiMing Li, Bing Fan, YaWei Xu, Different β-Blockers and Initiation Time in Patients Undergoing Noncardiac Surgery, The American Journal of the Medical Sciences, 2014, 347, 3, 235

    CrossRef

  5. 5
    Stephanie Chen, Stavros Tourkodimitris, Tatjana Lukic, Economic impact of switching from metoprolol to nebivolol for hypertension treatment: a retrospective database analysis, Journal of Medical Economics, 2014, 1

    CrossRef

  6. 6
    Mona Feiner, Christian Laforsch, Thomas Letzel, Juergen Geist, Sublethal effects of the beta-blocker sotalol at environmentally relevant concentrations on the New Zealand mudsnail Potamopyrgus antipodarum, Environmental Toxicology and Chemistry, 2014, 33, 9
  7. 7
    Madhu V. Singh, Mark W. Chapleau, Sailesh C. Harwani, Francois M. Abboud, The immune system and hypertension, Immunologic Research, 2014, 59, 1-3, 243

    CrossRef

  8. 8
    V. Dissanayake, M. Wahl, Encyclopedia of Toxicology, 2014,

    CrossRef

  9. 9
    Paul M Vanhoutte, Yuansheng Gao, Beta blockers, nitric oxide, and cardiovascular disease, Current Opinion in Pharmacology, 2013, 13, 2, 265

    CrossRef

  10. 10
    Sander Land, William E. Louch, Steven A. Niederer, Jan Magnus Aronsen, Geir Christensen, Ivar Sjaastad, Ole M. Sejersted, Nicolas P. Smith, Beta-Adrenergic Stimulation Maintains Cardiac Function in Serca2 Knockout Mice, Biophysical Journal, 2013, 104, 6, 1349

    CrossRef

  11. 11
    Catarina Pereira-Leite, Cláudia Carneiro, José X. Soares, Carlos Afonso, Cláudia Nunes, Marlene Lúcio, Salette Reis, Biophysical characterization of the drug–membrane interactions: The case of propranolol and acebutolol, European Journal of Pharmaceutics and Biopharmaceutics, 2013, 84, 1, 183

    CrossRef

  12. 12
    Sze Wa Chan, Miao Hu, Sara Shun Wah Ko, Catherine Wing Yan Tam, Benny Siu Pong Fok, Ophelia Qi Ping Yin, Moses Sing Sum Chow, Brian Tomlinson, CYP2C19 genotype has a major influence on labetalol pharmacokinetics in healthy male Chinese subjects, European Journal of Clinical Pharmacology, 2013, 69, 4, 799

    CrossRef

  13. 13
    Greg L. Plosker, Landiolol: A Review of its use in Intraoperative and Postoperative Tachyarrhythmias, Drugs, 2013, 73, 9, 959

    CrossRef

  14. 14
    Moo-Sik Lee, Andreas J. Flammer, Amir Lerman, The Decline Effect in Cardiovascular Medicine: Is the Effect of Cardiovascular Medicine and Stent on Cardiovascular Events Decline Over the Years?, Korean Circulation Journal, 2013, 43, 7, 443

    CrossRef

  15. 15
    Timothy H. Self, Jessica L. Wallace, Judith E. Soberman, Cardioselective Beta-Blocker Treatment of Hypertension in Patients with Asthma: When Do Benefits Outweigh Risks?, Journal of Asthma, 2012, 49, 9, 947

    CrossRef

  16. 16
    Julia Vogler, Lars Eckardt, Pharmacology of myocardial calcium-handling, Wiener Medizinische Wochenschrift, 2012, 162, 13-14, 311

    CrossRef

  17. 17
    Luc Poirier, Yves Lacourcière, The Evolving Role of β-Adrenergic Receptor Blockers in Managing Hypertension, Canadian Journal of Cardiology, 2012, 28, 3, 334

    CrossRef

  18. 18
    Sze Wa Chan, Miao Hu, Brian Tomlinson, The pharmacogenetics of β-adrenergic receptor antagonists in the treatment of hypertension and heart failure, Expert Opinion on Drug Metabolism & Toxicology, 2012, 8, 7, 767

    CrossRef

  19. You have free access to this content19
    Keith C. Ferdinand, A Compendium of Antihypertensive Therapy, The Journal of Clinical Hypertension, 2011, 13, 9
  20. 20
    Gitte Lund Christensen, Mark Aplin, Jakob Lerche Hansen, Therapeutic Potential of Functional Selectivity in the Treatment of Heart Failure, Trends in Cardiovascular Medicine, 2010, 20, 7, 221

    CrossRef